We've been covering Abiomed's Impella 2.5 left ventricular assist pump for many years now, and finally at AdvaMed 2010 we got a chance to see the device in action. Here's a company rep demonstrating how much power a tiny minimally invasive implantable heart pump can generate:
Impella 2.5 archives on Medgadget...
...
January 28th, 2010
The next iteration of Abiomed's Impella heart assist pump may be getting an optical pressure sensor built by Opsens of Quebec, Canada. A partnership just announced between the two companies includes plans to integrate Opsens' fiber optic sensors into the Impella to help clinicians monitor intracardiac/intraarterial pressure in real...
January 26th, 2010Last week, surgeons from the Mount Sinai School of Medicine in New York held a broadcast of a live complicated cath lab procedure involving Abiomed's Impella 2.5 left ventricular assist pump. The patient had a severely decreased left ventricular function and required hemodynamic assistance while rotational atherectomy was conducted and...
September 24th, 2009
The latest results from trials examining Abiomed's Impella 2.5 Percutaneous Circulatory Support System, the world's smallest left ventricle heart pump, are in, and they give the company, us and hoping clinicians a happy feeling. The big hurdle that the company has to overcome is to convince cardiologists that Impella devices are easy to...
April 27th, 2009
Abiomed, Inc. is reporting that the FDA has issued 510(k) clearance for the company's Impella® 5.0 and Impella® LD Circulatory Support Devices. The Impella® 5.0 is shown above, and Impella® LD is in the lower picture. As we have said before, the big trick is for the company to convince cardiologists and cardiac...
March 12th, 2009
A multicenter prospective feasibility study of the Impella 2.5 temporary cardiac assist device (The PROTECT I Trial), published in Journal of the American College of Cardiology, has found that the device is "easy to implant, and provides excellent hemodynamic support during high-risk PCI." That is good news for Abiomed, the manufacturer...
June 2nd, 2008
Abiomed's Impella 2.5 Percutaneous Circulatory Support System, the world's smallest left ventricle heart pump, has been approved by the FDA for use in patients for periods up to six hours. The device is designed to augment cardiac output in patients with acute left ventricular failure by up to 2.5 liters per minute. Medgadget has been...
March 17th, 2008
The FDA today gave approval to Abiomed to proceed with a clinical study of the Impella® 2.5 Circulatory Support System for patients with acute myocardial infarction (AMI). (2.5 refers to the ability of the device to augment the cardiac output by 2.5 liters per minute.) We've been following Impella, a ventricular assist device...
February 8th, 2006
Impella Recover line of cardiac support devices, manufactured by Impella CardioSystems GmbH, has received the highest approval level for reimbursement by the German governmental authority for healthcare (InEK). We have covered the technology in 2004. Since then the company has introduced a number of devices for a variety of supports:...
December 11th, 2004BBC News reports:
Doctors at Hammersmith Hospital in London carried out the procedure using the world's smallest heart support system - a device just 4mm wide.It was inserted into an artery in the groin and passed up into the heart.The pump, removed a day later, assisted the patient's heart in the crucial few hours after coronary artery...
November 16th, 2011Abiomed (Danvers, MA) has announced the introduction of a synchronized minimally invasive implantable cardiac assist device at the American Heart Association Scientific Sessions in Orlando, FL. Developed to treat patients with chronic moderate heart failure, the Symphony improves coronary perfusion and cardiac output. The device is...
